WHO official urges science-based, non-discriminatory Covid-19 restrictions

A senior official of the WHO has urged countries to take science-based precautionary Covid-19 entry restrictions that are proportionate and non-discriminatory

WHO
IANS Copenhagen
2 min read Last Updated : Jan 11 2023 | 8:23 AM IST

A senior official of the WHO has urged countries to take science-based precautionary Covid-19 entry restrictions that are proportionate and non-discriminatory.

Hans Kluge, WHO's Regional Director for Europe, made the appeal at a press conference here on Tuesday.

"For those countries in our region introducing precautionary travel measures at this time, we are calling for such to be rooted in science, to be proportionate and non-discriminatory," Kluge said.

"Scientifically, there is no immediate threat for the European region at this point in time based on the information we have from China, because the (virus) variants that are circulating in China are also circulating in Europe," Kluge told Xinhua.

"We share the current view of the European Centre for Disease Control (ECDC) that the ongoing surge in China is not anticipated to significantly impact the Covid-19 epidemiological situation in the WHO European Region at this time," he said.

Kluge reiterated the importance of scientific surveillance and criticised certain countries in the region for having significantly reduced their surveillance capacity for Covid-19 detection, Xinhua news agency reported.

According to Kluge, it might be risky to ignore other significant aspects of the evolution of the virus, such as the Omicron XBB.1.5 recombinant variant, which has rapidly spread throughout the US and is currently expanding in the European region.

He called on countries to take on even more responsibility, including increasing vaccine uptake in general populations, providing additional vaccine doses to priority groups, promoting mask-wearing both indoors and on public transportation, ventilating crowded and public spaces, and providing early and appropriate treatment to patients at risk of severe diseases.

--IANS

int/khz/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusWHO

First Published: Jan 11 2023 | 8:23 AM IST

Next Story